SG Americas Securities LLC Buys 782,888 Shares of Agilent Technologies, Inc. $A

SG Americas Securities LLC boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 3,091.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 808,215 shares of the medical research company’s stock after acquiring an additional 782,888 shares during the period. SG Americas Securities LLC’s holdings in Agilent Technologies were worth $109,974,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Capital A Wealth Management LLC lifted its position in shares of Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares during the period. Board of the Pension Protection Fund bought a new position in shares of Agilent Technologies in the fourth quarter worth $27,000. Davis Capital Management acquired a new position in Agilent Technologies in the third quarter valued at about $28,000. Physician Wealth Advisors Inc. lifted its position in Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares during the period. Finally, State of Wyoming bought a new stake in Agilent Technologies during the second quarter worth about $35,000. 87.41% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies Trading Up 0.6%

A opened at $112.02 on Tuesday. The company has a market cap of $31.66 billion, a P/E ratio of 24.73, a PEG ratio of 2.34 and a beta of 1.31. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The company’s 50 day moving average is $126.15 and its 200-day moving average is $135.35. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.Agilent Technologies’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio is 22.52%.

Analyst Upgrades and Downgrades

A has been the topic of several recent analyst reports. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price on the stock. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $155.00 to $160.00 in a report on Monday, January 5th. UBS Group reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Morgan Stanley decreased their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Finally, Bank of America upped their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $161.20.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.